..in the New England Journal of Medicine Chinese researchers have published positive trial results of simnotrelvir, an oral antiviral that can shorten the duration of mild to moderate COVID-19 symptoms.
The world’s renewable energy grew at its fastest rate in the past 25 years in 2023, the International Energy Agency reported Thursday in its first assessment since nations agreed in December on ambitious new targets to slow dangerous climate change.
In a new study in JAMA Network Open, authors review 28,000 interviews on vaccine uptake and hesitancy conducted in Hong Kong and Singapore from February 2020 through January 2022 to determine what was driving vaccine refusal.
China's Ministry of Culture and Tourism announced group travel could continue to 78 nations including the two popular destinations as well as Australia, Britain, Germany, Qatar and South Korea.